Flomark: safer hospital infusions through pioneering devices and data analytics

保持正确的液体平衡对患者的康复尤为重要。然而，20%接受静脉输液的患者由于静脉输液不正确而出现医疗并发症。我们将开发三项创新来解决液体平衡管理中的三个紧迫问题1)医院滴注在所有住院患者中，80%的住院患者使用重力输液装置(“滴注”)将液体直接输送到患者的静脉(输液)。但在85%的情况下，滴头使用不当，导致患者补液过快或过慢。我们已经申请了一种改进的滴头，**Flomark消耗品**。它使用直观，更可靠，节省了工作人员的时间，而且成本与最先进的滴头相同。我们将寻求监管部门的批准，测试和制造这一产品。目前还没有能够测量这个流量范围的流量计。2)输液泵在许多医院输液时，使用的是静脉输液泵。目前的泵无法感知流体的流动速度，因此必须依赖昂贵而笨重的电池和执行器来输送流体。我们将结合Flomark消耗品和电子产品来轻松感知和调节流量，创建**Flomark调节器**。这将是一个泵的成本的一小部分，更容易使用，并且有更少的缺点。我们的目标是生产生产前的原型。3)液体平衡在重症监护病房(ICU)中，液体平衡(患者的液体输入与液体输出之比)非常重要。虽然重症监护的资源很多，但这是人工监测和计算的，而且有35%的时间是不准确的。与心脏和呼吸监测不同，液体输入和输出没有实时数据馈送，尽管它被公认为重要。我们将修改Flomark消耗品以测量液体输出(通过导管)，并使用相同的Flomark调节器设计来检测这一点。这将允许为重症监护患者的液体输入和输出产生准确的实时数据-这是一个真正的变革性步骤。此外，我们将构建软件来分析这些数据，以预测患者的潜在伤害(**Flomark软件平台**)，并支持知情的临床决策和处方。这三项创新将极大地提高液体管理的效率和安全性。它们将颠覆当前的行业，以更低的成本提供更好的产品，并改善数据，从而改善医疗保健，从而为世界各地的医疗保健提供者节省大量资金。**可根据要求提供参考**

Maintaining correct fluid balance is particularly important for patient recovery. However, 20% of patients receiving intravenous (IV) fluids suffer medical complications because of incorrect IV administration.We will develop three innovations to address three pressing problems in fluid balance management.1) Hospital dripsIn 80% of all hospital admissions, a gravity administration set ("drip") is used to convey fluids directly into the patient's veins (infusion). But 85% of the time, the drip is used incorrectly, resulting in patients getting fluid too quickly or too slowly.We have patented an improved drip, the **Flomark Consumable**. It is intuitive to use, more reliable, saves staff time, and is the same cost as state-of-art drips. We will seek regulatory approval, test and manufacture this product. No flow meter capable of measuring this flow range is currently available.2) Infusion pumpsDuring many hospital infusions, an IV pump is used. Current pumps cannot sense how fast the fluid is flowing, and therefore must rely on expensive and heavy batteries and actuators to deliver fluid flow.We will combine the Flomark Consumable with electronics to easily sense and regulate flow, creating the **Flomark Regulator**. This will be a fraction of the cost of a pump, be easier to use, and have fewer drawbacks. We aim to produce a pre-production prototype.3) Fluid balanceIn intensive care (ICU), fluid balance (a patient's fluid input compared with fluid output) is very important. Although intensive care is highly resourced, this is monitored and calculated manually, and done inaccurately 35% of the time. Unlike cardiac and respiratory monitoring, there is no real-time data feed for fluid input and output, despite its acknowledged importance.We will modify the Flomark Consumable to measure fluid output (via a catheter), sensing this with the same Flomark Regulator design. This will allow accurate real time data to be produced for fluid _input and output_ for intensive care patients - a truly transformative step. Further to this, we will build software to analyse this data to predict potential patient harm (the **Flomark Software Platform**), and support informed clinical decisions and prescribing.These three innovations will vastly improve efficiency and safety in fluid management. They will disrupt the current industry, provide improved products for less cost, and improve data and thus care, saving healthcare providers worldwide a huge amount of money.**REFERENCES AVAILABLE ON REQUEST**